Neuronet (Efficiently Networking European Neurodegeneration Research, https://www.imi-neuronet.org/) just launched a new version of their Decision Tool to support engagement with Regulatory and Health Technology Assessment (HTA) bodies. The Decision Tool provides a clickable overview of the processes and procedures for HTA and regulatory interactions at different stages of the development pipeline to help ensure that the outputs being developed by Innovative Medicines Initiative research projects are relevant for regulatory and HTA settings, where applicable.
Neuronet, a Coordination and Support Action aiming to support and better integrate projects of the IMI neurodegeneration research portfolio aims to develop tools and services to support IMI neurodegeneration projects in areas where unmet needs have been identified, which include the need for further support for interactions with HTA and regulatory agencies.
The Decision Tool can be accessed through the Neuronet Knowledge Base, here: https://kb.imi-neuronet.org/